NEW YORK and LONDON, March 04, 2024 (GLOBE NEWSWIRE) -- Intelligent Scopes Corp, specializing in state-of-the-art image enhancement and precision AI software solutions for gastroenterology and urology, is pleased to announce the completion of its AI platform for gastroenterology, namely, Helga AI-GEP™. The platform will offer computer aided devices for detection, classification and characterization of lesions and tissue irregularities in the colon (colon cancer) and the upper gastrointestinal tract (esophageal and gastric cancer).

LONDON and NEW YORK, Dec. 21, 2023 (GLOBE NEWSWIRE) -- Intelligent Scopes Corp, a subsidiary of Claritas HealthTech Ltd. is pleased to announce it has entered into a know-how agreement with Mayo Clinic to develop artificial intelligence (AI) solutions for surgical and endoscopic imaging in the field of urology. Combining the research capabilities and clinical expertise of Mayo Clinic, with the technology of Intelligent Scopes in image enhancement and expertise in development of precision AI diagnostic tools, this collaboration aims to deliver software tools that aid urologists in the detection, surgery, and post-treatment surveillance.

LONDON and NEW YORK, Nov. 12, 2023 (GLOBE NEWSWIRE) -- Claritas HealthTech (Claritas), announces that its subsidiary, Intelligent Scopes Corp (ISC), a USA headquartered company focusing on research, development, and delivery of AI-assisted diagnostic solutions for endoscopy in urology and gastroenterology, will lead the worldwide delivery and deployment of CystoSmart™, an AI diagnostic tool for bladder cancer detection.

LONDON and NEW YORK, Nov. 03, 2023 (GLOBE NEWSWIRE) -- Claritas HealthTech (Claritas) a leader in medical image enhancement and AI diagnostic software solutions, is pleased to announce it has established Intelligent Scopes Corp (ISC), a USA headquartered company to focus on the long-term research and development, and delivery of its endoscopic image processing and AI-assisted diagnostic solutions for urology and gastroenterology.

LONDON and SINGAPORE, Nov. 30, 2022 (GLOBE NEWSWIRE) -- Claritas HealthTech (“Claritas”), a healthcare technology company specializing in medical image enhancement and Artificial Intelligence (AI) assisted diagnostic tools, announces today that it is commencing clinical validation of CystoSmart™. CystoSmart™ is an image enhancement and AI diagnostic tool for bladder cancer detection in images (videos and camera stream) seen on white light cystoscopy and narrow band imaging (NBI) cystoscopy.